Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford University has won £14 million in new European Research Council (ERC) funding.

Image courtesy of Shutterstock

Created to support innovative, high-impact research across the academic disciplines, the ERC offer 5-year grants to outstanding scientists and top researchers working in academia across Europe. Since it was founded in 2007 the funding body has awarded close to €12 billion across more than 7,000 grants.

The ERC has announced that it will award a total of 329 consolidator grants as part of its EU Horizon 2020 research programme. The fund is worth a total of €630 million and will have a far-reaching impact on science and beyond. Of this figure, more than €15 million (£14 million) will be given to Oxford University projects, bringing the University’s total amount of ERC funding received this year to nearly €30 million.

The research initiatives chosen cover a range of scientific disciplines across the Mathematical, Physical and Life Sciences, Medical Sciences, Social Sciences and the Humanities Divisions.

Find out more (University of Oxford website)

Similar stories

Researchers set out steps to address mental health effects of the pandemic on young people

Researchers have outlined 14 steps that schools, mental health services and policymakers can take to help children and young people whose mental health has been affected by the COVID-19 pandemic.

Anti-cancer drug derived from fungus shows promise in clinical trials

A new industry-academic partnership between the University of Oxford and biopharmaceutical company NuCana as found that chemotherapy drug NUC-7738, derived from a Himalayan fungus, has 40 times greater potency for killing cancer cells than its parent compound.

No benefit of convalescent plasma for critically ill COVID-19 patients

A large study of over 2000 COVID-19 patients has found that giving critically ill patients blood plasma from recovered COVID-19 patients did not significantly reduce deaths, or the need for intensive care support such as being put on a ventilator machine.

Increased infectiousness of coronavirus variants explained

Researchers from the Universities of Oxford and Dundee have made a discovery that helps explain why variations in the virus causes COVID-19 to spread so rapidly.

RECOVERY Trial paper wins BMJ’s 2021 UK Research Paper of the Year Award

For the second year in a row, The British Medical Journal have selected a publication co-authored by Oxford University researchers for their prestigious UK Research Paper of the Year Award. This award recognises original UK research that has the potential to contribute significantly to improving health and healthcare.

Researchers awarded Wellcome Innovator Grant to investigate role of brainstem nucleus in human consciousness

Researchers at Oxford University have received a prestigious Wellcome Innovator Grant for investigating the role of the pedunculopontine nucleus (PPN) – a brainstem nucleus – in human consciousness.